Published in Crit Care Med on May 01, 2003
Randomized Trial of Communication Facilitators to Reduce Family Distress and Intensity of End-of-Life Care. Am J Respir Crit Care Med (2016) 1.71
Training nurses for interdisciplinary communication with families in the intensive care unit: an intervention. J Palliat Med (2011) 1.70
Estimating the effect of palliative care interventions and advance care planning on ICU utilization: a systematic review. Crit Care Med (2015) 1.68
Discussion of treatment trials in intensive care. J Crit Care (2013) 1.58
Prospective study of a proactive palliative care rounding intervention in a medical ICU. Intensive Care Med (2015) 1.40
Mortality probability model III and simplified acute physiology score II: assessing their value in predicting length of stay and comparison to APACHE IV. Chest (2009) 1.18
Physicians' experience with surrogate decision making for hospitalized adults. J Gen Intern Med (2009) 1.15
Intensive care unit cultures and end-of-life decision making. J Crit Care (2007) 1.15
The changing role of palliative care in the ICU. Crit Care Med (2014) 1.10
Evidence-based palliative care in the intensive care unit: a systematic review of interventions. J Palliat Med (2014) 1.05
A systematic review of communication quality improvement interventions for patients with advanced and serious illness. J Gen Intern Med (2012) 0.98
Nursing Roles and Strategies in End-of-Life Decision Making in Acute Care: A Systematic Review of the Literature. Nurs Res Pract (2011) 0.97
Development and evaluation of an interprofessional communication intervention to improve family outcomes in the ICU. Contemp Clin Trials (2012) 0.96
Is it safe? Talking to teens with HIV/AIDS about death and dying: a 3-month evaluation of Family Centered Advance Care (FACE) planning - anxiety, depression, quality of life. HIV AIDS (Auckl) (2010) 0.92
Implementation of improvement strategies in palliative care: an integrative review. Implement Sci (2015) 0.91
A conceptual model of the role of communication in surrogate decision making for hospitalized adults. Patient Educ Couns (2011) 0.87
Involvement of ICU families in decisions: fine-tuning the partnership. Ann Intensive Care (2014) 0.82
Impact of critical care medicine training programs' palliative care education and bedside tools on ICU use at the end of life. J Grad Med Educ (2014) 0.80
Nurse-perceived barriers to effective communication regarding prognosis and optimal end-of-life care for surgical ICU patients: a qualitative exploration. J Palliat Med (2012) 0.79
Palliative care in neonatal neurology: robust support for infants, families and clinicians. J Perinatol (2015) 0.78
Economic implications of end-of-life care in the ICU. Curr Opin Crit Care (2014) 0.78
Potential Influence of Advance Care Planning and Palliative Care Consultation on ICU Costs for Patients With Chronic and Serious Illness. Crit Care Med (2016) 0.78
Developing a Research Agenda for Integrating Palliative Care into Critical Care and Pulmonary Practice To Improve Patient and Family Outcomes. J Palliat Med (2017) 0.75
Moral Distress in the Everyday Life of an Intensivist. Front Pediatr (2016) 0.75
Economic Feasibility of Staffing the Intensive Care Unit with a Communication Facilitator. Ann Am Thorac Soc (2016) 0.75
Perceptions of the appropriateness of care in California adult intensive care units. Crit Care (2015) 0.75
An intensive communication intervention for the critically ill. Am J Med (2000) 3.32
Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity (1999) 3.01
Anion-exchange mechanisms in bacteria. Microbiol Rev (1990) 1.47
Surfactant protein D deficiency influences allergic immune responses. Clin Exp Allergy (2004) 1.28
Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med (2001) 1.22
Variable stoichiometry of phosphate-linked anion exchange in Streptococcus lactis: implications for the mechanism of sugar phosphate transport by bacteria. Proc Natl Acad Sci U S A (1986) 1.22
Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. Am J Respir Crit Care Med (1998) 1.22
Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury. Am J Respir Cell Mol Biol (2001) 1.15
Inflammation and airway function in asthma: what you see is not necessarily what you get. Am J Respir Crit Care Med (1998) 1.08
Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. J Clin Invest (1998) 0.99
Ibuprofen causes reduced toxic effects of interleukin 2 administration in patients with metastatic cancer. Arch Surg (1989) 0.98
Adoptive immunotherapy of human cancer using low-dose recombinant interleukin 2 and lymphokine-activated killer cells. Cancer Res (1988) 0.95
Exhaled nitric oxide following repeated spirometry or repeated plethysmography in healthy individuals. Am J Respir Crit Care Med (2000) 0.95
Evaluation of a model for improving emergency medical and trauma services for children in rural areas. Ann Emerg Med (1997) 0.92
A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem Biophys Res Commun (2000) 0.89
Acute and chronic effects of allergic airway inflammation on pulmonary nitric oxide production. Am J Physiol (1997) 0.89
Variant eotaxin: its effects on the asthma phenotype. J Allergy Clin Immunol (2001) 0.83
Massive myocardial necrosis in thrombotic thrombocytopenic purpura: a case report and review of the literature. Arch Pathol Lab Med (1999) 0.81
Substance P-induced histamine release in tracheally perfused guinea pig lungs. J Appl Physiol (1985) (1995) 0.81
Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms. Oncogene (1999) 0.81
IL-4 differentially regulates eotaxin and MCP-4 in lung epithelium and circulating mononuclear cells. Am J Physiol Lung Cell Mol Physiol (2001) 0.80
Fetal alveolar epithelial cells contain [D-Ala(2)]-deltorphin I-like immunoreactivity: delta- and mu-opiate receptors mediate opposite effects in developing lung. Am J Respir Cell Mol Biol (2001) 0.80
Exhaled nitric oxide following leukotriene E(4) and methacholine inhalation in patients with asthma. Am J Respir Crit Care Med (2000) 0.80
Differential regulation of eotaxin expression by TNF-alpha and PMA in human monocytic U-937 cells. Am J Physiol (1998) 0.78
Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to the CD3 complex. Cancer Res (1990) 0.78
Syntaxin 1A is transiently expressed in fetal lung mesenchymal cells: potential developmental roles. Am J Physiol (1999) 0.77
Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans. Cancer Immunol Immunother (1989) 0.77
Epithelial cells are a major cellular source of the chemokine eotaxin in the guinea pig lung. Allergy Asthma Proc (1998) 0.76
Machine gunner's recovery. Mil Med (1996) 0.75
"Exhaled nitric oxide during exercise: site of release and modulation by ventilation and blood flow". J Appl Physiol (1985) (1996) 0.75
The biological effects of immunosuppression on cellular immunotherapy. Surg Oncol (1992) 0.75